|
| Markets |
Home| Wound Care Increasingly, the treatment of both acute and chronic wounds is focussing active involvement in the body’s natural processes to improve and accelerate healing. Materials are crucial to this process, by improving the environment for the healing process which, for whatever reason, is currently hostile. This approach is applicable to most of the current challenges in treating wounds, including severe burns, venous leg ulcers, diabetic foot ulcers, scar reduction and corneal damage. Altrika’s Myskin™ and Cryoskin™ products are available for the treatment of burns and have significant potential to treat chronic skin ulcers. Altrika also has IP in the field of materials for stem cell delivery to the cornea for therapeutic benefit, with future plans to enter clinical trials at Moorfields Eye Hospital, one of the leading eye treatment and research units in the world. |
